Cover Image
市場調查報告書

Bioprojet SCR的產品平台分析

Bioprojet SCR - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 259388
出版日期 內容資訊 英文 27 Pages
訂單完成後即時交付
價格
Back to Top
Bioprojet SCR的產品平台分析 Bioprojet SCR - Product Pipeline Review - 2015
出版日期: 2015年04月15日 內容資訊: 英文 27 Pages
簡介

Bioprojet SCR是總公司設置於法國的製藥企業,其產品有口服侯補藥水,兒童用鼻腔噴霧,肺動脈高血壓的治療藥前列環素衍生物,牛奶過敏診斷藥等。

本報告提供Bioprojet SCR 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,並彙整最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

目錄

Bioprojet SCR 基本資料

  • Bioprojet SCR 概要
  • 主要資訊
  • 企業資料

Bioprojet SCR :R&D概要

  • 主要的治療範圍

Bioprojet SCR :開發平台評估

  • 各開發階段的開發中產品
  • 單劑產品

Bioprojet SCR :開發中產品概況

  • 後期階段產品開發中產品
    • 申請登記前的產品/聯合治療模式
    • 第三階段的產品/聯合治療模式
  • 臨床階段的開發中產品
    • 第二階段的產品/聯合治療模式
    • 第一階段的產品/聯合治療模式

Bioprojet SCR:藥物簡介

  • pitolisant
  • dexecadotril
  • BP-1.4979
  • BP-1.3656

Bioprojet SCR :開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Bioprojet SCR :最新的開發平台資訊

Bioprojet SCR :開發暫停中的計劃

Bioprojet SCR :總公司和子公司的所在地

  • 總公司

附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC06976CDB

Summary

Global Markets Direct's, 'Bioprojet SCR - Product Pipeline Review - 2015', provides an overview of the Bioprojet SCR's pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Bioprojet SCR's, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Bioprojet SCR including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Bioprojet SCR's human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Bioprojet SCR's pipeline products

Reasons to buy

  • Evaluate Bioprojet SCR's strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Bioprojet SCR in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Bioprojet SCR's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Bioprojet SCR and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Bioprojet SCR
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Bioprojet SCR and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Bioprojet SCR Snapshot
    • Bioprojet SCR Overview
    • Key Information
    • Key Facts
  • Bioprojet SCR - Research and Development Overview
    • Key Therapeutic Areas
  • Bioprojet SCR - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Bioprojet SCR - Pipeline Products Glance
    • Bioprojet SCR - Late Stage Pipeline Products
      • Pre-Registration Products/Combination Treatment Modalities
      • Phase III Products/Combination Treatment Modalities
    • Bioprojet SCR - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
  • Bioprojet SCR - Drug Profiles
    • pitolisant
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • dexecadotril
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BP-1.4979
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • BP-1.3656
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Bioprojet SCR - Pipeline Analysis
    • Bioprojet SCR - Pipeline Products by Target
    • Bioprojet SCR - Pipeline Products by Route of Administration
    • Bioprojet SCR - Pipeline Products by Molecule Type
    • Bioprojet SCR - Pipeline Products by Mechanism of Action
  • Bioprojet SCR - Recent Pipeline Updates
  • Bioprojet SCR - Dormant Projects
  • Bioprojet SCR - Locations And Subsidiaries
    • Head Office
    • Other Locations & Subsidiaries
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Bioprojet SCR, Key Information
  • Bioprojet SCR, Key Facts
  • Bioprojet SCR - Pipeline by Indication, 2015
  • Bioprojet SCR - Pipeline by Stage of Development, 2015
  • Bioprojet SCR - Monotherapy Products in Pipeline, 2015
  • Bioprojet SCR - Pre-Registration, 2015
  • Bioprojet SCR - Phase III, 2015
  • Bioprojet SCR - Phase II, 2015
  • Bioprojet SCR - Phase I, 2015
  • Bioprojet SCR - Pipeline by Target, 2015
  • Bioprojet SCR - Pipeline by Route of Administration, 2015
  • Bioprojet SCR - Pipeline by Molecule Type, 2015
  • Bioprojet SCR - Pipeline Products by Mechanism of Action, 2015
  • Bioprojet SCR - Recent Pipeline Updates, 2015
  • Bioprojet SCR - Dormant Developmental Projects,2015
  • Bioprojet SCR, Subsidiaries

List of Figures

  • Bioprojet SCR - Pipeline by Top 10 Indication, 2015
  • Bioprojet SCR - Pipeline by Stage of Development, 2015
  • Bioprojet SCR - Monotherapy Products in Pipeline, 2015
  • Bioprojet SCR - Pipeline by Top 10 Target, 2015
  • Bioprojet SCR - Pipeline by Top 10 Molecule Type, 2015
  • Bioprojet SCR - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top